Integrating Addiction Services Improves Outcomes for Severe Eye Infections Tied to Injection Drug Use

A new study conducted by Eric Gaier, MD, PhD, and Dean Eliott, MD, from Mass Eye and Ear, a member of the Mass General Brigham healthcare system, investigated the impact of substance use disorder interventions on ophthalmic outcomes for patients with injection drug use-associated endogenous endophthalmitis. The significant findings were published in Ophthalmology Retina.

Study Rationale: Addressing Missed Opportunities

Individuals who use injection drugs face an elevated risk of severe eye infections, specifically endogenous endophthalmitis. This condition, caused by bacteria or fungi entering the bloodstream and reaching the eye, often presents as a medical emergency. While these patients receive acute vision care, the underlying substance use disorder is frequently unaddressed.

Researchers identified these encounters as critical, often missed, opportunities to connect patients with evidence-based addiction treatments.

Research Objectives

The study aimed to determine two primary outcomes:

• Whether involving addiction consult services in patient care increased access to medications for opioid use disorder.
• Which clinical or substance-related factors are associated with worse visual outcomes, particularly in the context of increased fentanyl use.

Methodology

Researchers reviewed the clinical records of patients treated for injection drug use-associated endogenous endophthalmitis at Mass General Brigham over a six-year period. The review included an examination of both ophthalmic outcomes, such as vision changes and complications, and addiction-related care. This covered whether an addiction consult service was involved and if medications for opioid use disorder were initiated.

Key Findings

The study revealed a critical connection between addiction services and treatment access.

The initiation of medications for opioid use disorder occurred exclusively when an addiction consult service was involved. Without formal addiction consultation, eligible patients did not receive these treatments.

From an ophthalmic perspective, most patients experienced improvements in vision. However, a concerning factor emerged: individuals who reported fentanyl use had significantly worse outcomes, with more than a five-fold increased probability of severe vision loss. These results indicate fentanyl as a dangerous factor for both overdose risk and irreversible visual impairment.

Real-World Implications

The study suggests that ophthalmologists can contribute beyond vision care by facilitating connections to life-saving addiction treatments. For patients with injection drug use-related infections, an ophthalmology visit may represent a rare interaction with the healthcare system.

Integrating addiction consult services during these critical ophthalmology visits can directly influence patient survival, not just their sight.

The research underscores the importance of addressing substance use disorder concurrently with acute medical problems to prevent both vision loss and other serious complications.